SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001640334-24-000051
Filing Date
2024-01-12
Accepted
2024-01-12 17:11:16
Documents
70
Period of Report
2023-11-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q lxrp_10q.htm   iXBRL 10-Q 803324
2 CERTIFICATIONS lxrp_ex311.htm EX-31.1 12276
3 CERTIFICATIONS lxrp_ex312.htm EX-31.2 12274
4 CERTIFICATIONS lxrp_ex321.htm EX-32.1 4550
5 CERTIFICATIONS lxrp_ex322.htm EX-32.2 4256
11 lxrp_10qimg19.jpg GRAPHIC 1582
  Complete submission text file 0001640334-24-000051.txt   4549041

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA lxrp-20231130.xsd EX-101.SCH 48231
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE lxrp-20231130_lab.xml EX-101.LAB 271554
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lxrp-20231130_cal.xml EX-101.CAL 44775
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lxrp-20231130_pre.xml EX-101.PRE 224903
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lxrp-20231130_def.xml EX-101.DEF 104423
64 EXTRACTED XBRL INSTANCE DOCUMENT lxrp_10q_htm.xml XML 740409
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

IRS No.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-Q | Act: 34 | File No.: 001-39874 | Film No.: 24532780
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)